Drug Profile
Methylphenidate extended release - ALZA
Alternative Names: Concerta; JNS-001; Oros® methylphenidateLatest Information Update: 06 Dec 2023
Price :
$50
*
At a glance
- Originator ALZA Corporation
- Developer Janssen Pharmaceutical KK
- Class Behavioural disorder therapies; Neuroprotectants; Nootropics; Phenylacetates; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor modulators; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Attention-deficit hyperactivity disorder